by Mark Curtis | Feb 18, 2016
Welcome to your Cell Therapy Deal Review for the month of January. Things got off to a quick start with a number of cell-based immunotherapy companies announcing deals and research collaborations out of the gate, including a third acquisition by Juno. Juno...
by Nicole Kuchinsky | Feb 17, 2016
Cell therapy is not a new idea. Bone marrow transplantation—the first ever cell therapy—has been around since the 1950s. Over half a century of research has brought important advancements, yet this technology has struggled to make it to prime time. Understandably,...
by Stacey Johnson | Feb 12, 2016
Are you a glass half full or half empty kind of person? If you’re the former, and you think more is better, being inclusive and diverse benefits humanity, and that children are our future, then this should be in your sweet spot (meaning “an optimum point or...
by Hamideh Emrani | Feb 10, 2016
Another in the series: “What drives research in the field of biomaterials?” “What makes Canada cool?” asks Dan Taekema of The Toronto Star, and among the handful of influential figures that he writes about is the “rock star” researcher, Professor Molly Shoichet. I was...
by Stacey Johnson | Feb 5, 2016
According to the World Health Organization, there were 8.2 million cancer related deaths in 2012 so by my calculations, that’s over 22,000 each day. Cancer has been on my mind a lot this week, and not just because yesterday was #WorldCancerDay. On February 1st, the...
by Erin Sugar | Jan 29, 2016
January is a month of resolutions. Whether it be dieting, exercising or finally taking up that project that you said you would begin a year ago, it is a month that typically sparks improvement. (By the way, how are your visits to the gym going?) While January marks...
by Stacey Johnson | Jan 22, 2016
Does it seem like regenerative medicine is having its moment in the sun? Last week, the news that GE Healthcare and the Centre for Commercialization of Regenerative Medicine (CCRM) are building a centre for advanced therapeutic cell technologies, with $20 million...
Comments